Method
Level · gp.fundamentals.debt_to_revenue
Raw value 244.94% · OPTIONAL
· Services-Motion Picture & Video Tape Production
RESEARCH SNAPSHOTLionsgate Studios Corp.'s latest supported as-filed period reports revenue of $776.6M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 244.94% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.37% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 6.97% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 47.67% · CORE
Level · gp.fundamentals.operating_margin
Raw value 3.30% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 5.29% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Capex / revenue changed -29 basis points from the comparable as-filed period.
Capital expenditure changed -17.1% from the comparable as-filed period.
Cash & equivalents changed +128.8% from the comparable as-filed period.
Debt changed +14.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
LION · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0002052959-26-000067SEC ↗8-KAug 6, 2026Period Aug 6, 20260002052959-26-000065SEC ↗8-KJul 23, 2026Period Jul 20, 20260002052959-26-000055SEC ↗4Jul 10, 2026Period Jul 8, 20260001193125-26-301179SEC ↗4/AJul 10, 2026Period Jul 3, 20260001254386-26-000004SEC ↗4Jul 6, 2026Period Jul 1, 20260001237441-26-000002SEC ↗4Jul 6, 2026Period Jul 1, 20260001971761-26-000004SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market SaleIndirect | 1,469,450 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market SaleIndirect | 3,701,988 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market SaleIndirect | 25,173,882 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 797,526 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Free-cash-flow proxy changed +248.4% from the comparable as-filed period.
Net income changed +73.6% from the comparable as-filed period.
Operating cash flow changed +274.5% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001558979-26-000003| Open Market PurchaseIndirect |
| 1,916,271 |
| — |
| — |
| Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 11,154,680 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 671,924 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market SaleIndirect | 499,765 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 499,765 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 15,804,919 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market SaleIndirect | 11,755,412 | — | — | Form 4 ↗ |
| Jul 8, 2026Filed Jul 10, 2026 | RACHESKY MARK H MDDirector | Open Market PurchaseIndirect | 11,755,412 | — | — | Form 4 ↗ |